AGTR1 and COVID-19: There was a trend toward increased prevalence of AT1R-Ab in COVID-19 cases versus controls (50% vs. 33%, p = 0.1) as well as in the subset of mild cases versus controls (55% vs. 31%, p = 0.07) (Fig 1A and 1B).